Year archive

Marvel Biosciences Corp. — 2025 filings

All 25 regulatory filings released by Marvel Biosciences Corp. (MRVL) in 2025, sourced directly from the official regulator.

25 Filings

2025 Period

2025 filings (25)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (F).pdf Regulatory Filings	2025-12-18	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-12-18	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2025-12-04	English
Letter from successor auditor.pdf Regulatory Filings	2025-09-18	English
Notice.pdf Regulatory Filings	2025-09-18	English
Letter from former auditor.pdf Regulatory Filings	2025-09-18	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-06-17	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-06-17	English
Interim MD&A - English.pdf Management Reports	2025-06-17	English
Interim financial statements/report – English.pdf Interim / Quarterly Report 9M 2025	2025-06-17	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2025-05-16	English
News release - English.pdf Capital/Financing Update	2025-05-13	English
News release - English.pdf Capital/Financing Update	2025-05-02	English
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2025-04-17	English
News release - English.pdf Regulatory Filings	2025-04-16	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-04-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-04-01	English
Interim MD&A - English.pdf Management Reports	2025-04-01	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H1 2025	2025-04-01	English
News release - English.pdf Capital/Financing Update	2025-03-28	English
News release - English.pdf Regulatory Filings	2025-03-17	English
News release - English.pdf Regulatory Filings	2025-03-13	English
News release - English.pdf Regulatory Filings	2025-03-11	English
Offering document - English.pdf Capital/Financing Update	2025-01-07	English
News release - English.pdf Regulatory Filings	2025-01-07	English